(Q80010826)

English

Imatinib mesylate for targeting the platelet-derived growth factor beta receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer--a dose-escalation Phase I trial

scientific article published on 01 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Imatinib mesylate for targeting the platelet-derived growth factor beta receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer--a dose-escalation Phase I trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

phase I clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gerhard Ehninger

6

object named as

Gerhard Ehninger

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

7

object named as

Elke Jäger

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Salah-Eddin Al-Batran

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Akin Atmaca

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Eberhard Schleyer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Claudia Pauligk

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Christian Hosius

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1897-1904

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Transport of molecules, particles, and cells in solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing tumor uptake of anticancer drugs with imatinib.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Hand-foot syndrome after dose-dense adjuvant chemotherapy for breast cancer: a case series

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Indications for imatinib mesylate therapy and clinical management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective kinase inhibition with daily imatinib intensifies toxicity of chemotherapy in patients with solid tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22622

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22622

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377918%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80010826&oldid=1751087132"